Andrews L S, Pohl L R, Hinson J A, Fisk C L, Gillette J R
Drug Metab Dispos. 1979 Sep-Oct;7(5):296-300.
During the sulfation of N-hydroxy-2-acetylaminofluorene (NOH-2AAF) by rat liver 100,000 g supernatant fraction in vitro, an unidentified metabolite is produced which accounts for 22% of the N-OH-2AAF metabolized. This product has been characterized as the 2AAF dimer, 1-(N-2'-fluorenylacetamido-2-acetylaminofluorene) by comparing its TLC, HPLC, UV, and mass spectral properties with a synthetic standard which was prepared from the reaction of N-acetoxy-2-acetylaminofluorene (N-AcO-2AAF) with 2AAF. Increasing amounts of 2AAF added to the incubation mixture of N-OH-[acetyl-14C]2AAF and rat liver 100,000 g supernatant fraction decreased the irreversible binding of 14C to protein, and increased the formation of 2AAF dimer proportionately. This suggests that the 2AAF dimer is formed from the reaction of 2AAF and the electrophilic species produced from the sulfated N-OH-2AAF. In the presence of the 9,000 g fraction of rat liver, the dimer of 2AAF was aroximately 1/25 as active as 2AAF in producing mutations in the Salmonella mutagenesis test system.
在大鼠肝脏100,000g上清液组分对N-羟基-2-乙酰氨基芴(NOH-2AAF)进行体外硫酸化过程中,会产生一种未鉴定的代谢产物,该产物占代谢的N-OH-2AAF的22%。通过将其薄层层析(TLC)、高效液相色谱(HPLC)、紫外(UV)和质谱性质与由N-乙酰氧基-2-乙酰氨基芴(N-AcO-2AAF)与2AAF反应制备的合成标准品进行比较,该产物已被鉴定为2AAF二聚体,即1-(N-2'-芴基乙酰胺基-2-乙酰氨基芴)。向N-OH-[乙酰基-14C]2AAF与大鼠肝脏100,000g上清液组分的孵育混合物中添加越来越多的2AAF,会降低14C与蛋白质的不可逆结合,并相应增加2AAF二聚体的形成。这表明2AAF二聚体是由2AAF与硫酸化的N-OH-2AAF产生的亲电物质反应形成的。在存在大鼠肝脏9,000g组分的情况下,在沙门氏菌诱变试验系统中,2AAF二聚体产生突变的活性约为2AAF的1/25。